146 related articles for article (PubMed ID: 20017105)
1. Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF.
Munivenkatappa R; Haririan A; Papadimitriou JC; Drachenberg CB; Dinits-Pensy M; Klassen DK
Histol Histopathol; 2010 Feb; 25(2):189-96. PubMed ID: 20017105
[TBL] [Abstract][Full Text] [Related]
2. Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experience.
Hamdy AF; Bakr MA; Ghoneim MA
Exp Clin Transplant; 2010 Dec; 8(4):283-91. PubMed ID: 21143093
[TBL] [Abstract][Full Text] [Related]
3. Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil.
Pardo-Mindán FJ; Errasti P; Panizo A; Sola I; de Alava E; Lozano MD
Nephron; 1999; 82(3):232-7. PubMed ID: 10395995
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
[TBL] [Abstract][Full Text] [Related]
5. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.
Loverre A; Ditonno P; Crovace A; Gesualdo L; Ranieri E; Pontrelli P; Stallone G; Infante B; Schena A; Di Paolo S; Capobianco C; Ursi M; Palazzo S; Battaglia M; Selvaggi FP; Schena FP; Grandaliano G
J Am Soc Nephrol; 2004 Oct; 15(10):2675-86. PubMed ID: 15466272
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.
Gelens MA; Steegh FM; van Hooff JP; van Suylen RJ; Nieman FH; van Heurn LW; Peutz-Kootstra CJ; Christiaans MH
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1010-7. PubMed ID: 22490875
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic tubular cell death during acute renal allograft rejection.
Wever PC; Aten J; Rentenaar RJ; Hack CE; Koopman G; Weening JJ; ten Berge IJ
Clin Nephrol; 1998 Jan; 49(1):28-34. PubMed ID: 9491283
[TBL] [Abstract][Full Text] [Related]
8. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
9. How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.
van Gelder T; Silva HT; de Fijter H; Budde K; Kuypers D; Mamelok RD; Armstrong VW; Oellerich M
Ther Drug Monit; 2011 Apr; 33(2):155-64. PubMed ID: 21383657
[TBL] [Abstract][Full Text] [Related]
10. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.
Smith KD; Wrenshall LE; Nicosia RF; Pichler R; Marsh CL; Alpers CE; Polissar N; Davis CL
J Am Soc Nephrol; 2003 Apr; 14(4):1037-45. PubMed ID: 12660339
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.
Boratyńska M; Banasik M; Patrzalek D; Szyber P; Klinger M
Transplant Proc; 2005 Mar; 37(2):839-42. PubMed ID: 15848550
[TBL] [Abstract][Full Text] [Related]
12. Role of Sirolimus in renal tubular apoptosis in response to unilateral ureteral obstruction.
Yang M; Zhuang YY; Wang WW; Zhu HP; Zhang YJ; Zheng SL; Yang YR; Chen BC; Xia P; Zhang Y
Int J Med Sci; 2018; 15(13):1433-1442. PubMed ID: 30443162
[TBL] [Abstract][Full Text] [Related]
13. Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.
Diekmann F; Gutiérrez-Dalmau A; López S; Cofán F; Esforzado N; Ricart MJ; Rossich E; Saval N; Torregrosa JV; Oppenheimer F; Campistol JM
Nephrol Dial Transplant; 2007 Aug; 22(8):2316-21. PubMed ID: 17452413
[TBL] [Abstract][Full Text] [Related]
14. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
[TBL] [Abstract][Full Text] [Related]
15. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
16. Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil.
Kamar N; Van TT; Ribes D; Modesto A; Cointault O; Lavayssière L; Ader JL; Durand D; Rostaing L
Exp Clin Transplant; 2006 Dec; 4(2):532-6. PubMed ID: 17238854
[TBL] [Abstract][Full Text] [Related]
17. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.
Franz S; Regeniter A; Hopfer H; Mihatsch M; Dickenmann M
Am J Kidney Dis; 2010 Feb; 55(2):335-43. PubMed ID: 19926370
[TBL] [Abstract][Full Text] [Related]
18. The absence of delayed graft function is predicted by the presence of manganese-superoxide dismutase in distal tubules of renal allografts.
Boom H; de Heer E; van der Wal A; Kruidenier L; de Fijter JW; Benediktsson H; Paul LC; van Es LA
Transplantation; 2005 Apr; 79(8):946-52. PubMed ID: 15849548
[TBL] [Abstract][Full Text] [Related]
19. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
Boratynska M; Banasik M; Patrzalek D; Klinger M
Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
[TBL] [Abstract][Full Text] [Related]
20. Kidney injury molecule-1 staining in renal allograft biopsies 10 days after transplantation is inversely correlated with functioning proximal tubular epithelial cells.
Bank JR; van der Pol P; Vreeken D; Monge-Chaubo C; Bajema IM; Schlagwein N; van Gijlswijk DJ; van der Kooij SW; Reinders MEJ; de Fijter JW; van Kooten C
Nephrol Dial Transplant; 2017 Dec; 32(12):2132-2141. PubMed ID: 29045706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
